• ホーム
  • 検索結果
  • Dynamic changes in the numbers of different subsets of peripheral blood NK cells in patients with systemic lupus erythematosus following classic therapy.

Dynamic changes in the numbers of different subsets of peripheral blood NK cells in patients with systemic lupus erythematosus following classic therapy.

Clinical rheumatology (2014-07-16)
Hongshuang Ma, Ling Zhao, Zhenyu Jiang, Yanfang Jiang, Li Feng, Zhuang Ye
要旨

Imbalance of natural killer (NK) cells is associated with the development of systemic lupus erythematosus (SLE). However, little is known about the dynamic changes on NK cells following therapy. This study aimed at examining the impact of classic therapies on the numbers of different subsets of NK cells in new-onset SLE patients. The numbers of different subsets of peripheral blood NK cells in 24 new-onset SLE patients before, 4 and 12 weeks post the classic therapies, and 7 healthy controls were determined by flow cytometry. The potential correlation between the numbers of NK cells and the values of clinical measures was analyzed. In comparison with that before treatment, the numbers of NK, NKG2C+, and KIR2DL3+ NK cells were significantly increased while the numbers of NKp46+ and NKG2A + NK cells significantly decreased at 4 and/or 12 weeks post the treatment only in the drug well-responding patients, but not in those poor responders (P < 0.05 for all). The numbers of NKG2C + NK cells were correlated positively with the levels of serum C3 while the numbers of KIR2DL3+ NK cells were correlated negatively with the scores of SLEDAI in these patients at 4 weeks post the treatment. The classic therapies modulated the numbers of some subsets of NK cells in drug well-responding SLE patients. The changes in the numbers of some subsets of NK cells may serve as biomarkers for evaluating the therapeutic responses of SLE.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
抗JAG2抗体 ウサギ宿主抗体, affinity isolated antibody
Sigma-Aldrich
モノクロナール抗CD56-FITC マウス宿主抗体, clone C5.9, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
抗JAG2 ウサギ宿主抗体, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
Sigma-Aldrich
ANTI-KLRC2 (N-TERM) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
Anti-KLRC1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-JAG2 antibody produced in mouse, clone 2D10, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-CD16 antibody produced in mouse, clone LNK16, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-CD16 antibody produced in mouse, clone 3G8, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-CD16 antibody produced in mouse, clone MEM-154, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
モノクローナル抗CD56抗体-FITC標識 マウス宿主抗体, clone MEM-188, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-NCR1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-JAG2 antibody produced in mouse, clone 1C5, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-KLRC1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-NCR3 antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-NCR1 antibody produced in rabbit, affinity isolated antibody
Sigma-Aldrich
Anti-KIR3DL1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-KLRC2 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-CD314 antibody produced in mouse, clone 1D11, purified immunoglobulin, buffered aqueous solution

ソーシャルメディア

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

研究、開発、製造

私たちは、バイオテクノロジーと医薬品の研究&開発および製造のソリューションとサービスを提供する、グローバルなライフサイエンス業界のリーディングサプライヤーです。

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates.All Rights Reserved.

当ウェブサイトのいかなる内容についても、許可なく複写することを禁じます。